WAYWaystar Holding Corp.
Is the price fair?
Undemanding: modest expectations priced in and cheap vs its sector.
Priced for ~2% a year FCF growth. The price bakes in little to no growth.
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
All from derived, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What WAY's price assumes
Waystar Holding Corp. trades at 38.1× earnings against 46.0× for the median Health Information Services name, cheaper than its own group.
Trailing P/E · Health Information Services median 46.0 · cheaper than the typical name in its group
- Price / sales
- 3.02
Price / sales · today's price, trailing year to Jun 30, 2026
- Free cash flow yield
- 6.8%
Free cash flow yield · Health Information Services median 6.3%
- Growth the price implies
- +1.6%
Growth the price implies · What free cash flow would have to do every year for a decade to justify today's price, discounted at 9.0%.
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 0.91
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 17.8
- EV / salestoday's price, trailing year to Jun 30, 2026
- 4.07
- Healthcare median P/E509 names
- 26.2
- Health Information Services median P/E25 names
- 46.0
- Free cash flow, trailing twelve months
- $246M
- Market capitalisation
- $3.64B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #2 of 20 by RyuScore